Speaker illustration

Doctor Akshay Suvas Desai

Brigham and Women's Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

Akshay S. Desai, MD, MPH, FACC, FHFSA is the Director of the Cardiomyopathy and Heart Failure Program in the Cardiovascular Medicine Division at Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School (Boston, USA). He divides his time between the clinical care of patients with advanced heart disease, including those with end-stage heart failure requiring mechanical circulatory support or cardiac transplantation, and clinical research, with an emphasis on the pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He has published extensively in the peer-reviewed medical literature and is active in both the conduct of clinical trials of novel therapies for patients with heart failure across the spectrum of ejection fraction and the design of innovative population-level strategies to reduce the burden of heart failure-associated morbidity and mortality. He is currently Deputy Editor for JACC: Heart Failure.

Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction

Event: ESC Congress 2019

Topic: Treatment

Session: Late Breaking Science in Heart Failure 1


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb